The Surgical Healing Problem
Post-surgical recovery — whether from orthopedic procedures, abdominal surgery, or soft tissue repair — follows a predictable healing cascade: inflammation, proliferation, and remodeling. Each phase has a specific timeline and can be disrupted by factors including poor nutrition, inadequate blood supply, and patient age. Peptide therapy research has targeted several of these phases.
BPC-157 and Surgical Anastomosis Research
Some of the most compelling BPC-157 GI research involves intestinal anastomosis healing — the reconnection of intestine after surgical resection. Rodent studies have shown significantly accelerated healing and improved structural integrity of anastomotic connections in BPC-157-treated animals. This has clinical implications for colorectal surgery patients, though no human trials exist.
Wound Healing Research
Multiple animal studies have found BPC-157 and TB-500 both accelerate superficial wound closure — a proxy for surgical incision healing. The TB-500 wound closure rate study (41% faster closure in one murine study) is often cited in this context.
Critical Consideration
Post-surgical use of any peptide therapy must be coordinated with your surgeon. Angiogenic effects of BPC-157 could theoretically affect healing in ways that are beneficial in most contexts but warrant surgical awareness in post-operative care. Never start a peptide protocol after surgery without your surgeon’s knowledge.